Search results
Found 14 matches for
Today University of Oxford and AstraZeneca researchers present a pooled analysis of Phase 3 trials of a vaccine against SARS-CoV-2 across two different dose regimens, resulting in an average efficacy of 70.4%.
Oxford Surgical Innovation Conference 2024
Innovation
Friday, 15 March 2024, 8.45am to 5.30pm
A showcase of recent innovations in surgical practice and policy in a hybrid in-person/virtual format, targeted at surgically inclined students, trainees and consultants.